Psychopharmacology is no longer open for submissions, but we welcome your contribution to other relevant Frontiers specialty sections. While this specialty section has now closed, its archive of articles represents its aim to contribute to the understanding of Psychopharmacology.
The section aimed to publish major insights into animal and human psychopharmacology, as well as the neurobiological basis of behavior induces by psychotropics. It welcomed papers concerned with the interplay between behavior and neurobiological analysis at all levels using psychotropics as tools including molecular biology, genetics, and morphological, biochemical, neurochemical, electrophysiological, neuroendocrinal and neuroimaging studies. While Psychopharmacology is primarily centered on animal behavior, human studies that can validate conclusions from animal research were also welcomed. In recent years, translational work has proven to be particularly suitable to address topics and questions related to psychopathology, with outstanding examples showing how animal studies can help identify key genetic mechanisms of behavioral deviation in humans and, conversely, how innovative findings in humans are directing essential work in animals. The ultimate goal of this section was to accelerate the progress in this research area at a critical time when we are facing multiple challenges: from the need to integrate findings obtained at different levels of analysis to the constant redefinition of topics and approaches that concern and characterize the field of psychopharmacology. We hope that this can continue through your collaborations to other specialty sections at Frontiers.